309 related articles for article (PubMed ID: 11181499)
1. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
[TBL] [Abstract][Full Text] [Related]
2. The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.
Washington CB; Wiltshire HR; Man M; Moy T; Harris SR; Worth E; Weigl P; Liang Z; Hall D; Marriott L; Blaschke TF
Drug Metab Dispos; 2000 Sep; 28(9):1058-62. PubMed ID: 10950849
[TBL] [Abstract][Full Text] [Related]
3. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats.
Shibata N; Kageyama M; Kishida T; Kimura K; Yoshikawa Y; Kuwahara T; Toh J; Shirasaka T; Takada K
Biopharm Drug Dispos; 2003 Nov; 24(8):335-44. PubMed ID: 14595702
[TBL] [Abstract][Full Text] [Related]
5. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.
Kays MB; White RL; Gatti G; Gambertoglio JG
Pharmacotherapy; 1992; 12(1):50-5. PubMed ID: 1549539
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.
Grub S; Delora P; Lüdin E; Duff F; Fletcher CV; Brundage RC; Kline MW; Calles NR; Schwarzwald H; Jorga K
Clin Pharmacol Ther; 2002 Mar; 71(3):122-30. PubMed ID: 11907486
[TBL] [Abstract][Full Text] [Related]
8. Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.
Sudhakaran S; Rayner CR; Li J; Kong DC; Gude NM; Nation RL
Br J Clin Pharmacol; 2007 Mar; 63(3):315-21. PubMed ID: 16981898
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective plasma protein binding of bimoclomol.
Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M
Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
[TBL] [Abstract][Full Text] [Related]
10. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
[TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.
Ribera E; Lopez RM; Diaz M; Pou L; Ruiz L; Falcó V; Crespo M; Azuaje C; Ruiz I; Ocaña I; Clotet B; Pahissa A
Antimicrob Agents Chemother; 2004 Nov; 48(11):4256-62. PubMed ID: 15504850
[TBL] [Abstract][Full Text] [Related]
12. Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir.
Parker AJ; Houston JB
Drug Metab Dispos; 2008 Jul; 36(7):1375-84. PubMed ID: 18426953
[TBL] [Abstract][Full Text] [Related]
13. [Characterization of propofol binding to plasma proteins and possible interactions].
Garrido MJ; Jiménez RM; Rodríguez-Sasiaín JM; Aguirre C; Aguilera L; Calvo R
Rev Esp Anestesiol Reanim; 1994; 41(6):308-12. PubMed ID: 7838996
[TBL] [Abstract][Full Text] [Related]
14. Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoprotein.
Yoo SD; Holladay JW; Fincher TK; Baumann H; Dewey MJ
J Pharmacol Exp Ther; 1996 Mar; 276(3):918-22. PubMed ID: 8786570
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective binding of zopiclone to human plasma proteins.
Fernandez C; Gimenez F; Thuillier A; Farinotti R
Chirality; 1999; 11(2):129-32. PubMed ID: 9951403
[TBL] [Abstract][Full Text] [Related]
16. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
17. Binding of chlorpheniramine enantiomers to human plasma proteins.
Hiep BT; Gimenez F; Khanh VU; Hung NK; Thuillier A; Farinotti R; Fernandez C
Chirality; 1999; 11(5-6):501-4. PubMed ID: 10368923
[TBL] [Abstract][Full Text] [Related]
18. Effect of altered serum protein binding on propranolol distribution into milk in the lactating rabbit.
Fleishaker JC; McNamara PJ
J Pharmacol Exp Ther; 1988 Mar; 244(3):925-8. PubMed ID: 3252038
[TBL] [Abstract][Full Text] [Related]
19. Phencyclidine blood protein binding: influence of protein, pH and species.
Owens SM; Mayersohn M; Woodworth JR
J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
[TBL] [Abstract][Full Text] [Related]
20. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
Plum A; Müller LK; Jansen JA
Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
